Country: Armenia
Language: English
Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
paracetamol
Farmaclair
N02BE01 օրիգինալ դեղի առաջին դեղաձև, դեղաչափ
paracetamol
125mg (10/2x5/)
suppositories rectal
125mg (10/2x5/)
OTC
Registered
2021-05-16
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Panadol Baby 125 mg Rectal Suppositories 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each suppository contains Paracetamol 125 mg. Complete list of excipients is given in section 6.1. 3. PHARMACEUTICAL FORM Rectal Suppository White or almost white homogeneous fatty-looking suppositories of a conical shape, without physical defects and visible impurities. 4. CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS Symptomatic treatment of pain from mild to moderate intensity and / or fever. 4.2. POSOLOGY AND METHOD OF ADMINISTRATION _Dosage regimen _ Panadol Baby suppositories 125 mg are for children aged 6 to 18 months (with body weight of 7 to 10 kg). Use the lowest recommended doses to achieve effect within the shortest possible time. If necessary, repeat after 6 hours. Do not use more than 4 suppositories per day. When used in children, it is necessary to observe the dosages determined in accordance with the body weight of the child and choose the required dosage form. Maximum daily doses should not exceed 60 mg / kg body weight of the child, which should be divided into 4 applications, that is, 15 mg / kg body weight every 6 hours. Due to potential toxicity of such medicine rectal administration of paracetamol should be as short as possible. Not more than four doses in any 24 hour period. Maximum duration of continued use without medical advice: 3 days. In case of diarrhea, do not use this medicine. Systematic use of this medicine allows to avoid sharp jumps in temperature and fluctuations in the intensity of pain. _Special Patient groups _ _Patients with impaired renal function _ Patients with renal insufficiency should consult their doctor before taking this medicine. In adults in case of renal insufficiency, while using this medicine without consulting a doctor, it is recommended to reduce the dose and increase the minimal interval between 2 doses according to the following table: Creatinine clearance Interval between doses Creatinine clearance > Read the complete document